Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lieberman

Showing results (1071-1080 of 1,142) with videos related to

Pageof 115
Sort By:
The Journal of Clinical Psychiatry|September 7, 2010
Treatment outcomes of patients with tardive dyskinesia and chronic schizophreniaStanley N Caroff, Vicki G Davis, Del D Miller, et al.
Molecular Psychiatry|March 6, 2013
The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophreniaT A Lett, M M Chakravarty, M M Chakavarty, et al.
JAMA Psychiatry|February 5, 2015
Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging studyMark Slifstein, Elsmarieke van de Giessen, Jared Van Snellenberg, et al.
Contraception|February 7, 2018
Simultaneous quantitation of multiple contraceptive hormones in human serum by LC-MS/MSSteven W Blue, Andrea J Winchell, Amy V Kaucher, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 10, 2008
Time-lapse mapping of cortical changes in schizophrenia with different treatmentsPaul M Thompson, George Bartzokis, Kiralee M Hayashi, et al.
Gastroenterology|May 30, 2013
Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohortSrinivas Gaddam, Mandeep Singh, Gokulakrishnan Balasubramanian, et al.
Nature Communications|November 21, 2018
H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progressionS P Rowbotham, F Li, A F M Dost, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 26, 2010
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophreniaJoseph L McClay, Daniel E Adkins, Karolina Aberg, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2008
Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stageJennifer C Naylor, Christine M Hulette, David C Steffens, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2013
Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasiaRajeswari Anaparthy, Srinivas Gaddam, Vijay Kanakadandi, et al.
Pageof 115

Showing results (1071-1080 of 1,142) with videos related to

Sort By:
Pageof 115
The Journal of Clinical Psychiatry|September 7, 2010
Treatment outcomes of patients with tardive dyskinesia and chronic schizophreniaStanley N Caroff, Vicki G Davis, Del D Miller, et al.
Molecular Psychiatry|March 6, 2013
The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophreniaT A Lett, M M Chakravarty, M M Chakavarty, et al.
JAMA Psychiatry|February 5, 2015
Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging studyMark Slifstein, Elsmarieke van de Giessen, Jared Van Snellenberg, et al.
Contraception|February 7, 2018
Simultaneous quantitation of multiple contraceptive hormones in human serum by LC-MS/MSSteven W Blue, Andrea J Winchell, Amy V Kaucher, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 10, 2008
Time-lapse mapping of cortical changes in schizophrenia with different treatmentsPaul M Thompson, George Bartzokis, Kiralee M Hayashi, et al.
Gastroenterology|May 30, 2013
Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohortSrinivas Gaddam, Mandeep Singh, Gokulakrishnan Balasubramanian, et al.
Nature Communications|November 21, 2018
H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progressionS P Rowbotham, F Li, A F M Dost, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 26, 2010
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophreniaJoseph L McClay, Daniel E Adkins, Karolina Aberg, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2008
Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stageJennifer C Naylor, Christine M Hulette, David C Steffens, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2013
Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasiaRajeswari Anaparthy, Srinivas Gaddam, Vijay Kanakadandi, et al.
Pageof 115